Cell Death and Disease (Jun 2024)

ER-mitochondria association negatively affects wound healing by regulating NLRP3 activation

  • Caterina Licini,
  • Gianluca Morroni,
  • Guendalina Lucarini,
  • Veronica Angela Maria Vitto,
  • Fiorenza Orlando,
  • Sonia Missiroli,
  • Gloria D’Achille,
  • Mariasole Perrone,
  • Tatiana Spadoni,
  • Laura Graciotti,
  • Giorgia Bigossi,
  • Mauro Provinciali,
  • Annamaria Offidani,
  • Monica Mattioli-Belmonte,
  • Oscar Cirioni,
  • Paolo Pinton,
  • Oriana Simonetti,
  • Saverio Marchi

DOI
https://doi.org/10.1038/s41419-024-06765-9
Journal volume & issue
Vol. 15, no. 6
pp. 1 – 14

Abstract

Read online

Abstract Methicillin-resistant Staphylococcus aureus (MRSA) is the most common causative agent of acute bacterial skin and skin-structure infections (ABSSSI), one of the major challenges to the health system worldwide. Although the use of antibiotics as the first line of intervention for MRSA-infected wounds is recommended, important side effects could occur, including cytotoxicity or immune dysregulation, thus affecting the repair process. Here, we show that the oxazolidinone antibiotic linezolid (LZD) impairs wound healing by aberrantly increasing interleukin 1 β (IL-1β) production in keratinocytes. Mechanistically, LZD triggers a reactive oxygen species (ROS)-independent mitochondrial damage that culminates in increased tethering between the endoplasmic reticulum (ER) and mitochondria, which in turn activates the NLR family pyrin domain-containing 3 (NLRP3) inflammasome complex by promoting its assembly to the mitochondrial surface. Downregulation of ER-mitochondria contact formation is sufficient to inhibit the LZD-driven NLRP3 inflammasome activation and IL-1β production, restoring wound closure. These results identify the ER-mitochondria association as a key factor for NLRP3 activation and reveal a new mechanism in the regulation of the wound healing process that might be clinically relevant.